You have 9 free searches left this month | for more free features.

SA14-14-2 vaccine

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Encephalitis, Japanese Trial (Live Attenuated Japanese Encephalitis SA-14-14-2 Vaccine)

Completed
  • Encephalitis, Japanese
  • Live Attenuated Japanese Encephalitis SA-14-14-2 Vaccine
  • (no location specified)
Sep 24, 2020

Encephalitis, Japanese, Measles, Mumps Trial in Manila (Live attenuated SA 14-14-2 Japanese Encephalitis vaccine, Measles,

Completed
  • Encephalitis, Japanese
  • +3 more
  • Live attenuated SA 14-14-2 Japanese Encephalitis vaccine
  • Measles, mumps, rubella vaccine
  • Manila, Philippines
    Research Institute for Tropical Medicine
Sep 18, 2020

Japanese Encephalitis Trial in Homagama, Kolonnawa, Moratuwa (Live, Attenuated Japanese Encephalitis SA 14-14-2 Vaccine (LJEV))

Completed
  • Japanese Encephalitis
  • Live, Attenuated Japanese Encephalitis SA 14-14-2 Vaccine (LJEV)
  • Homagama, District Of Colombo, Sri Lanka
  • +2 more
Mar 18, 2020

Encephalitis, Japanese B Trial in Manila (Live Japanese encephalitis vaccine SA 14-14-2 (LJEV), Measles Vaccine (MV))

Completed
  • Encephalitis, Japanese B
  • Live Japanese encephalitis vaccine SA 14-14-2 (LJEV)
  • Measles Vaccine (MV)
  • Manila, Philippines
    Research Institute for Tropical Medicine
Feb 25, 2020

COVID-19 Trial in Chengdu (LYB002V14, LYB002V14A, LYB002CA)

Active, not recruiting
  • COVID-19
  • LYB002V14
  • +2 more
  • Chengdu, Sichuan, China
    Affiliated Hospital of North Sichuan MedicalCollege
Jun 29, 2023

Influenza, Human Trial (sa-mRNA vaccine Dose 1, sa-mRNA vaccine Dose 2, sa-mRNA vaccine Dose 3)

Not yet recruiting
  • Influenza, Human
  • sa-mRNA vaccine Dose 1
  • +4 more
  • (no location specified)
Sep 7, 2023

Two Domestic HPV Vaccines and Imported HPV Vaccines in Women

Not yet recruiting
  • HPV Infection
  • +2 more
  • Follow up
  • Fuzhou, Fujian, China
    Fujian Maternity and Child Health Hospital
Nov 16, 2023

Schistosomiasis Mansoni, Schistosomiasis Haematobium, Vaccination; Infection Trial in Saint Louis (Sm14 recombinant vaccine+

Recruiting
  • Schistosomiasis Mansoni
  • +2 more
  • Sm14 recombinant vaccine+ GLA-SE adjuvant
  • Saint Louis, Senegal
    Biomedical Research Center EPLS
Dec 13, 2022

COVID-19 Trial in Nanjing (Two doses of middle-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14,

Recruiting
  • COVID-19
  • Two doses of middle-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14
  • +7 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Diseases Control and Prevention
Mar 28, 2022

Smallpox, Monkeypox, Cowpox Trial in Novosibirsk (NIOCH-14, 200 mg capsule: 1 capsule (200 mg) of NIOCH-14 once orally,

Completed
  • Smallpox
  • +3 more
  • NIOCH-14, 200 mg capsule: 1 capsule (200 mg) of NIOCH-14 once orally
  • +5 more
  • Novosibirsk, Koltsovo, Novosibirsk Region, Russian Federation
    Federal State Budgetary Healthcare Institution - Medical and San
Jul 27, 2023

Pain Trial in Seville (Painless Vaccination)

Completed
  • Pain
  • Painless Vaccination
  • Seville, Andalucia, Spain
    Distrito Sanitario Aljarafe-Sevilla Norte
Aug 16, 2023

Papillomavirus Infections Trial in Quzhou, Taizhou (9vHPV vaccine)

Active, not recruiting
  • Papillomavirus Infections
  • 9vHPV vaccine
  • Quzhou, Zhejiang, China
  • +1 more
Sep 1, 2022

Healthy Trial (BI 1810631 (C-14) formulation 1, BI 1810631, BI 1810631 (C-14) formulation 2)

Not yet recruiting
  • Healthy
  • BI 1810631 (C-14) formulation 1
  • +2 more
  • (no location specified)
May 25, 2023

Dengue, Dengue Fever, Dengue Hemorrhagic Fever Trial in Worldwide (Live, attenuated, dengue serotype 1, 2, 3, 4 virus, Placebo:

Completed
  • Dengue
  • +2 more
  • Live, attenuated, dengue serotype 1, 2, 3, 4 virus
  • Placebo: Sodium chloride (NaCl) 0.9%
  • Denpasar, Bali, Indonesia
  • +11 more
Mar 10, 2022

NSCLC Trial in Guangzhou (PLB1001)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Aug 15, 2023

Healthy Trial in Groningen (BI 764198 (C-14) (approach 1), BI 764198 (C-14) (approach 2))

Recruiting
  • Healthy
  • BI 764198 (C-14) (approach 1)
  • BI 764198 (C-14) (approach 2)
  • Groningen, Netherlands
    ICON
May 8, 2023

Healthy Volunteers Trial in Leeds (E7386 Tablet, (14C)E7386 Capsule, (14C)E7386)

Recruiting
  • Healthy Volunteers
  • E7386 Tablet
  • +2 more
  • Leeds, United Kingdom
    Labcorp Clinical Research Unit
Oct 31, 2022

HPV InfectioN, HPV-Related Carcinoma Trial in China (Recombinant 14-Valent Human Papillomavirus Vaccine(Insect Cell), )

Active, not recruiting
  • HPV InfectioN
  • HPV-Related Carcinoma
  • Recombinant 14-Valent Human Papillomavirus Vaccine(Insect Cell)
  • placebo
  • Nanning, Guangxi, China
  • +4 more
Sep 10, 2023

Diphtheria, Tetanus, Pertussis Trial (LBVD (Hexavalent vaccine), Pentavalent vaccine and Inactivated Polio vaccine (Sabin

Not yet recruiting
  • Diphtheria
  • +5 more
  • LBVD (Hexavalent vaccine)
  • Pentavalent vaccine and Inactivated Polio vaccine (Sabin strains)
  • (no location specified)
Jul 13, 2022

VIDAS® NEPHROCLEAR Diagnostic Accuracy Study

Active, not recruiting
  • Acute Kidney Injury
  • +2 more
  • VIDAS® NEPHROCLEAR™ CCL14 Test
  • Washington, District of Columbia
  • +1 more
Sep 7, 2023

Gastrointestinal Stromal Tumors Trial in Houston (Regorafenib)

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2023

Dengue Fever, Dengue Hemorrhagic Fever, Human Papillomavirus Disease Trial in Mexico City (CYD Dengue Vaccine, Human

Completed
  • Dengue Fever
  • +2 more
  • CYD Dengue Vaccine
  • Human Papillomavirus Bivalent [Types 16 and 18] Vaccine, Recombinant
  • Mexico City, Mexico
    (unnamed)
Mar 15, 2022

Light Chain (AL) Amyloidosis, CCND1 Translocation, Venetoclax Trial (Venetoclax, Dexamethasone Oral)

Not yet recruiting
  • Light Chain (AL) Amyloidosis
  • +2 more
  • (no location specified)
Aug 16, 2023

Healthy Participants Trial in Groningen (Oral [14C]PF-07081532, Oral PF-07081532 and IV [14C]PF-07081532)

Recruiting
  • Healthy Participants
  • Oral [14C]PF-07081532
  • Oral PF-07081532 and IV [14C]PF-07081532
  • Groningen, Netherlands
    PRA Health Sciences
Jan 5, 2023